Myocardial Infarction News and Research

RSS

Smoke-free laws lead to fewer heart attacks

A recent decline in the incidence of myocardial infarction in Olmsted County, Minnesota, USA, could be due to the implementation of smoke-free laws, researchers suggest.

5 Nov 2012

Research roundup: Lowering health costs of the poorest sick; Local variations in health spending

Olmstead County, Minn., which earlier required just restaurants to be smoke-free, enacted a law in 2007 that banned smoking in all workplaces. Researchers reported "a substantial decline in the incidence of MI from 18 months before the smoke-free restaurant law was implemented to 18 months after the comprehensive smoke-free workplace law was implemented 5 years later.

3 Nov 2012

Cardio exercise OK in high-risk CVD patients

US study results indicate that cardiopulmonary exercise is well tolerated, even when performed by individuals with high-risk cardiovascular disease.

1 Nov 2012

Smoke-free laws lead to fewer heart attacks

A recent decline in the incidence of myocardial infarction in Olmsted County, Minnesota, USA, could be due to the implementation of smoke-free laws, researchers suggest.

31 Oct 2012

Smoke-free workplace law implementation linked with decline in incidence of heart attacks

A decline in the incidence of myocardial infarction (MI, heart attack) in one Minnesota county appears to be associated with the implementation of smoke-free workplace laws, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

30 Oct 2012

Isis commences ISIS-FXIRx Phase 2 study in knee replacement surgery patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 comparator-controlled study evaluating ISIS-FXIRx in patients undergoing knee replacement surgery, also referred to as total knee arthroplasty (TKA).

29 Oct 2012

Drug-eluting stents exhibit some benefits in patients over 80

Rarely tested in patients over the age of 80, a study found that drug-eluting stents exhibited some benefits over bare-metal stents, though both types of stents demonstrated a clinical benefit. Results of the XIMA trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

29 Oct 2012

St. Luke's cardiologist wins TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award

Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

29 Oct 2012

Trial finds benefits in using radial approach for primary angioplasty in heart attack patients

A study found several benefits in using the radial artery in the arm as the entry point for angioplasty or percutaneous coronary intervention (PCI) compared to the femoral artery in the leg. Results of the STEMI-RADIAL trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

29 Oct 2012

Intracoronary and IV abciximab during angioplasty do not result in differences in myocardial damage

A study confirmed no differences in various measures of heart damage, according to cardiac magnetic resonance (MRI) imaging, in patients receiving the anti-clotting medication abxicimab directly into the heart (intracoronary) compared to those receiving it intravenously (IV).

26 Oct 2012

Prasugrel reduces cardiovascular events among patients managed medically for ACS

A study has found that the anti-clotting medication prasugrel reduced cardiovascular events among patients who present with an acute coronary syndrome and are managed medically after an angiogram is performed to determine coronary anatomy.

25 Oct 2012

Simple-to-use risk score can identify low-risk STEMI patients for early discharge

A simple-to-use risk score can identify low-risk patients following a severe heart attack (STEMI) and may provide an opportunity to employ early discharge strategies to reduce length of hospital stay and save hospital costs without compromising the safety of the patient, based on a study presented by the Minneapolis Heart Institute Foundation on Oct. 23 at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference.

24 Oct 2012

Schizophrenia patients at increased death risk after AMI

Results from a Canadian study show that patients with schizophrenia are significantly more likely to die after acute myocardial infarction than other patients.

23 Oct 2012

Gender gap in myocardial infarction mortality

Women are more likely to die from a myocardial infarction than men, according to research presented at the Acute Cardiac Care Congress 2012. The gender gap in mortality was independent of patient characteristics, revascularisation delays and revascularisation modalities.

20 Oct 2012

Chest pain patients who call ambulance have quicker treatment and better survival: Study

The Acute Cardiac Care Congress 2012 is the first annual meeting of the newly launched Acute Cardiovascular Care Association of the European Society of Cardiology.

20 Oct 2012

Coronary angioplasty improves survival in all patients with out of hospital cardiac arrest

Coronary angioplasty improves survival in all patients with out of hospital cardiac arrest, according to research presented at the Acute Cardiac Care Congress 2012. The study was presented by Dr Annamaria Nicolino from the Santa Corona General Hospital in Pietra Ligure, Italy.

20 Oct 2012

Soccer training can prevent cardiovascular disease in middle-aged men with hypertension

Playing soccer (football) could be the best way for people with high blood pressure, known as hypertension, to improve their fitness, normalise their blood pressure and reduce their risk of stroke.

16 Oct 2012

METASTROKE refines genetic stroke culprits

An analysis from the METASTROKE collaboration confirms an increased stroke risk associated with four previously reported genetic loci and shows that these are specific to certain stroke subtypes.

15 Oct 2012

METASTROKE refines genetic stroke culprits

An analysis from the METASTROKE collaboration confirms an increased stroke risk associated with four previously reported genetic loci and shows that these are specific to certain stroke subtypes.

12 Oct 2012

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

Pfizer Inc. announced top-line results today from a Phase 3 open-label long-term safety study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic, non-cancer pain.

12 Oct 2012

Myocardial Infarction News and Research

Smoke-free laws lead to fewer heart attacks

Research roundup: Lowering health costs of the poorest sick; Local variations in health spending

Cardio exercise OK in high-risk CVD patients

Smoke-free laws lead to fewer heart attacks

Smoke-free workplace law implementation linked with decline in incidence of heart attacks

Isis commences ISIS-FXIRx Phase 2 study in knee replacement surgery patients

Drug-eluting stents exhibit some benefits in patients over 80

St. Luke's cardiologist wins TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award

Trial finds benefits in using radial approach for primary angioplasty in heart attack patients

Intracoronary and IV abciximab during angioplasty do not result in differences in myocardial damage

Prasugrel reduces cardiovascular events among patients managed medically for ACS

Simple-to-use risk score can identify low-risk STEMI patients for early discharge

Schizophrenia patients at increased death risk after AMI

Gender gap in myocardial infarction mortality

Chest pain patients who call ambulance have quicker treatment and better survival: Study

Coronary angioplasty improves survival in all patients with out of hospital cardiac arrest

Soccer training can prevent cardiovascular disease in middle-aged men with hypertension

METASTROKE refines genetic stroke culprits

METASTROKE refines genetic stroke culprits

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News